LOS ANGELES, February 24, 2026--(BUSINESS WIRE)--MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of ...

Bridging therapy was administered to 90% of apheresed patients, with chemotherapy ± radiotherapy used in 53% and targeted ...

Colorectal cancer (CRC) has a high global impact as the second leading cause of cancer associated deaths. There are several preventive measures that can reduce your risk of developing colorectal ...

Please provide your email address to receive an email when new articles are posted on . Menopausal hormone therapy is perceived as increasing CVD risk, but that is only true in certain populations.

Across treatment classes, CH associated with increased therapy-related cytopenias, particularly neutropenia, and DNMT3A/TET2 ...

You may feel relief and curiosity at once: new studies are narrowing how hormone therapy affects dementia risk, but the answer isn’t a simple yes or no. Evidence now suggests hormone therapy can ...

After 6 months of hormone therapy, men with prostate cancer showed worsening lipid profiles, with 21% showing increased risk of cardiovascular disease based on general population tools. Men receiving ...

Prostate cancer epidemiology has been marked overall by a downward risk migration over time. However, in some populations, both in the United States and abroad, many men are still diagnosed with ...

Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer Drugs Strategies aimed at reducing preventable ...

New ACC/AHA guidelines provide updated recommendations for dyslipidemia management, focusing on atherogenic lipoproteins and risk assessment.